Surfing the MASH Tsunami

Surfing the MASH Tsunami

Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL

Tämä podcast on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi podcastin jaksot saattavat sisältää mainontaa.

Jaksot(1073)

International NASH Day is Here! - Ep 9

International NASH Day is Here! - Ep 9

Send us Fan Mail Surfing the NASH Tsunami celebrates a growing and increasingly important global event for the Fatty Liver community. Global Liver Institute President & CEO Donna Cryer joins the Surf...

11 Kesä 202054min

Diagnosing Diagnostics – Part I - Ep 8

Diagnosing Diagnostics – Part I - Ep 8

Send us Fan Mail Room for improvement GenFit Head of Global Diagnostics Suneil Hosmane joins the Surfers in exploring the current strengths and drawbacks of Fatty Liver diagnostics. The conversation ...

4 Kesä 202050min

NASH-Ville - Part 2: Better Days Ahead? - Ep 7

NASH-Ville - Part 2: Better Days Ahead? - Ep 7

Send us Fan Mail Reviewing press releases reporting preliminary findings from six recently announced Phase 2 trials Stephen Harrison leads the Surfers, with guest Louise Campbell, through an examinat...

28 Touko 20201h 1min

What’s in a Name: NAFLD or MAFLD? - Ep 6

What’s in a Name: NAFLD or MAFLD? - Ep 6

Send us Fan Mail Exploring the controversy over the name(s) to use when describing Fatty Liver disease(s) Professor Quentin Anstee joins the Surfers for a thoughtful consideration of the factors that...

21 Touko 202052min

Wild Times In NASH-Ville – Part I - Ep 5

Wild Times In NASH-Ville – Part I - Ep 5

Send us Fan Mail Clinical trial results that are changing how we look at NASH Stephen Harrison leads a review of two recent Phase 3 data statements: the outcome of GenFit’s RESOLVE-IT trial and Madri...

15 Touko 20201h 3min

When You Get To A Fork In The Road - Ep 4

When You Get To A Fork In The Road - Ep 4

Send us Fan Mail Three possible scenarios for development of the NASH market. Roger Green presents three possible directions for the NASH market over the next 5-10 years and asks our panelists, includ...

7 Touko 202059min

C-Suite COVID-19 Challenges - Ep 3

C-Suite COVID-19 Challenges - Ep 3

Send us Fan Mail Critical considerations for companies developing NASH drugs Peter Traber focuses on ways COVID-19 can affect drug development and broader corporate strategies while our panelists wei...

30 Huhti 202053min

Five $imple Pieces - Ep 2

Five $imple Pieces - Ep 2

Send us Fan Mail What investors want to know about NASH development during the pandemic. Yasmeen Rahimi poses five questions NASH investors ask her about the impact of COVID-19 on NASH clinical and c...

23 Huhti 202054min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
hippokrateen-vastaanotolla
utelias-mieli
rss-hereilla
filocast-filosofian-perusteet
tiedekulma-podcast
docemilia
rss-vaasan-yliopiston-podcastit
rss-tiedetta-vai-tarinaa
rss-totuuden-liepeilla
ihanat-ipanat
radio-antro
rss-bios-podcast
rss-poliisin-mieli
rss-ammamafia
rss-kasvikutsut